查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年北美上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式
市場調查報告書
商品編碼
1567860

到 2030 年北美上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式

North America Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 127 Pages | 訂單完成後即時交付

價格

2022年北美上游生物加工市場價值為39.5862億美元，預計到2030年將達到106.0338億美元；預計2022年至2030年複合年成長率為13.1%。

一次性生物反應器的商業用途推動了北美上游生物加工市場。

由於一次性生物反應器 (SUB) 結構堅固且性能優異，許多製造商正在開發一次性生物反應器 (SUB)，這對於生物製藥的商業製造是必需的。與生物膜形成、攪拌機制、生物反應器設計和感測器系統等相關技術的結合，導致實驗室和生產規模擴大採用一次性反應器。一次性生物反應器用於製造下一代細胞和基因療法，它們適用於連續生物加工。細胞培養過程的進步已經產生了更高的滴度和細胞密度，促進了 SUB 的採用。一次性生物反應器的運作污染風險低，生產週轉時間短，驗證時間短。在過去幾年中，一次性生物反應器在現代生物製藥製程中的使用有所增加，因為它們具有幫助提高靈活性、減少投資和限制營運成本的獨特能力。此外，許多公司還開發了一次性生物反應器來生產各種治療藥物。 2021 年 3 月，Thermo Fischer Scientific 推出了 3,000 L 和 5,000 L HyPerforma DynaDrive 一次性生物反應器。 Sartorius AG 提供各種一次性生物反應器。該公司提供適用於 10-15 mL 微型生物反應器規模的 ambr 15 和適用於 50-2000L 規模的 Biostat STR。隨後，一次性生物反應器在上游生物加工中的使用不斷增加。因此，擴大接受用於生產治療藥物的一次性生物反應器，推動了上游生物加工市場的發展。

北美上游生物加工市場概況

北美的上游生物加工市場分為美國、加拿大和墨西哥。北美市場的成長歸因於生物製藥和生物技術公司對生物反應器系統的需求不斷增加、市場參與者的顯著存在以及學術和研究機構不斷加大的研發力度。此外，製藥和生物技術公司的研究活動推動了北美上游生物加工市場的成長。

北美上游生物加工市場收入及 2030 年預測（百萬美元）

北美上游生物加工市場細分

北美上游生物加工市場根據產品類型、工作流程、使用類型、模式和國家進行細分。

根據產品類型，北美上游生物加工市場分為生物反應器/發酵槽、細胞培養、過濾器、袋子和容器等。 2022 年，生物反應器/發酵器服務佔據最大的市場佔有率。

根據工作流程，北美上游生物加工市場分為培養基製備、細胞培養和細胞分離。 2022 年，細胞分離佔據最大的市場佔有率。

就使用類型而言，北美上游生物加工市場分為一次性和多用途。 2022年一次性使用將佔據更大的市場佔有率

依模式分類，北美上游生物加工市場分為內部和外包。 2022 年，In-house 佔據了更大的市場佔有率。

依國家分類，北美上游生物加工市場分為美國、加拿大和墨西哥。 2022年，美國將主導北美上游生物加工市場。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Sartorius AG、Danaher Corp、Getinge AB、Merck KGaA、Corning Inc、Entegris Inc 和 PBS Biotech Inc 是北美上游生物加工市場的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美上游生物加工市場格局

  • 概述
  • PEST分析

第 5 章：北美上游生物加工市場 - 主要市場動態

  • 市場促進因素
    • 一次性生物反應器的商業用途
    • 生物製藥製造外包
    • 醫藥和生技產業快速成長
  • 市場限制
    • 嚴格的規範架構
  • 市場機會
    • 技術進步
  • 未來趨勢
    • 加大生醫產業研發投入
  • 促進因素和限制的影響：

第 6 章：上游生物加工市場 - 北美分析

第 7 章：北美上游生物加工市場分析 - 按產品類型

  • 生物反應器/發酵罐
  • 細胞培養
  • 過濾器
  • 袋子和容器
  • 其他

第 8 章：北美上游生物加工市場分析 - 按工作流程

  • 媒體準備
  • 細胞培養
  • 細胞分離

第 9 章：北美上游生物加工市場分析 - 按使用類型

  • 一次使用
  • 多用途

第 10 章：北美上游生物加工市場分析 - 按模式

  • 內部
  • 外包

第 11 章：北美上游生物加工市場 - 國家分析

  • 北美市場概況
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥

第 12 章：產業格局

  • 概述
  • 上游生物加工市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte. Ltd.
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris, Inc.
  • PBS Biotech, Inc.

第 14 章：附錄

Product Code: BMIRE00030683

The North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to grow at a CAGR of 13.1% from 2022 to 2030.

Commercial Use of Single-Use Bioreactors Fuels North America Upstream Bioprocessing Market.

Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market.

North America Upstream Bioprocessing Market Overview

The upstream bioprocessing market in North America is segmented into the US, Canada, and Mexico. Market growth in North America is attributed to the increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, the prominent presence of market players, and growing R&D efforts by academic and research institutes. In addition, research activities by pharmaceutical and biotechnology companies propel the upstream bioprocessing market growth in North America.

North America Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

North America Upstream Bioprocessing Market Segmentation

The North America upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country.

Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the North America upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

In terms of usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

By mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the North America upstream bioprocessing market is segmented into the US, Canada, and Mexico. The US dominated the North America upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc are some of the leading companies operating in the North America upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - North America Analysis

7. North America Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Upstream Bioprocessing Market - Country Analysis

  • 11.1 North America Market Overview
    • 11.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 US
      • 11.1.1.3 US: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Canada
      • 11.1.1.5 Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 Mexico
      • 11.1.1.7 Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte. Ltd.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sartorius AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Danaher Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 PBS Biotech, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 7. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 8. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 9. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 10. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 11. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 12. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 13. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 14. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 15. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 16. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 17. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 18. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 19. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 20. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 21. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Growth Strategies in Upstream Bioprocessing Market